Search results for "Highlights"
Manufacturer's trials find positive results for combo drug for type 2 diabetes
Tirzepatide, a not-yet-approved dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonist, was tested against placebo and semaglutide in recent studies.
https://diabetes.acponline.org/archives/2021/07/09/3.htm
9 Jul 2021
PPIs may have beneficial glycemic effects in patients with diabetes
A systematic review and meta-analysis found that proton-pump inhibitors (PPIs) improved glycemic indices in patients with diabetes and did not appear to affect risk for incident diabetes.
https://diabetes.acponline.org/archives/2021/07/09/2.htm
9 Jul 2021
ADA updates 2021 Standards of Care to address latest research on diagnosis, treatment
The American Diabetes Association (ADA) 2021 Standards of Medical Care in Diabetes now reflect new data on teplizumab and sodium-glucose cotransporter-2 inhibitors, as well as the effects of dapagliflozin and finerenone on patients with chronic kidney disease.
https://diabetes.acponline.org/archives/2021/07/09/1.htm
9 Jul 2021
Association between diabetes and worse COVID-19 outcomes more marked in younger adults
Among patients hospitalized with COVID-19, diabetes was a more significant risk factor for death, intensive care, or intubation in those younger than 50 years compared to older patients, a retrospective French study found.
https://diabetes.acponline.org/archives/2021/06/11/3.htm
11 Jun 2021
Depression associated with death in older patients with type 2 diabetes
A study that screened patients with type 2 diabetes in Spain for depression found that depression was associated with higher all-cause mortality in patients older than age 65 years, but not in younger patients.
https://diabetes.acponline.org/archives/2021/06/11/2.htm
11 Jun 2021
Review looks at metformin safety, effectiveness in patients with reduced renal function
Metformin appears to be associated with reduced mortality at estimated glomerular filtration rates as low as 45 mL/min/1.73 m2, but safety concerns arise with rates at or below 30 mL/min/1.73 m2.
https://diabetes.acponline.org/archives/2021/06/11/1.htm
11 Jun 2021
Younger age at type 2 diabetes onset linked to higher risk of subsequent dementia
An analysis of a prospective cohort study in the U.K. found that developing type 2 diabetes before age 70 years was associated with greater likelihood of having dementia, and dementia risk increased with longer duration of diabetes.
https://diabetes.acponline.org/archives/2021/05/14/3.htm
14 May 2021
More guideline-recommended diabetes care provided to older U.S. adults, not other age groups
From 2005 to 2018, the proportion of diabetes patients receiving care as recommended by the American Diabetes Association increased from 29.3% to 44.2% among those ages 65 years or older but did not change significantly for those ages 40 to 64 years (25.2% to 25.8%) or 20 to 39 years (9.9% to 26.0%).
https://diabetes.acponline.org/archives/2021/05/14/2.htm
14 May 2021
Meta-analysis quantifies survival gains from bariatric surgery
According to an analysis of studies of severely obese patients, metabolic-bariatric surgery was associated with median life expectancy gains of 9.3 years in patients with diabetes and 5.1 years in patients without diabetes.
https://diabetes.acponline.org/archives/2021/05/14/1.htm
14 May 2021
AHA issues policy statement on reducing lower-extremity amputations
Amputations among U.S. patients with diabetes decreased between 2000 and 2009 but increased by 50% from 2009 to 2015, leading the American Heart Association (AHA) to call for better identification and treatment of peripheral artery disease and propose policy solutions.
https://diabetes.acponline.org/archives/2021/04/09/3.htm
9 Apr 2021